Post‐colonoscopy upper gastrointestinal malignancies in positive immunochemical fecal occult blood test patients: An Australian data linkage study
Among individuals with a positive iFOBT in a bowel cancer screening program, the rates of gastric and esophageal cancers were 2.7 and 7.5 times higher than the general population. Adding gastroscopy to a colonoscopy for iFOBT-positive patients in cancer surveillance programs may be justifiable.
Authors
- Gerald Holtmann (ORCID: https://orcid.org/0000-0002-0206-2358)
- Natasha A. Koloski (ORCID: https://orcid.org/0000-0002-8647-5933)
- Ayesha Shah (ORCID: https://orcid.org/0000-0003-0710-1691)
- Sahar Pakneshan
- Nicholas Joseph Talley (ORCID: https://orcid.org/0000-0003-2537-3092)
- Naomi Moy (ORCID: https://orcid.org/0000-0003-0413-9053)
- Michael Jones (ORCID: https://orcid.org/0000-0003-0565-4938)
Institutions
- Translational Research Institute (AU)
- The University of Queensland (AU)
- Princess Alexandra Hospital (AU)
- University of Newcastle Australia (AU)
- Macquarie University (AU)
Publication Details
- Journal
- Journal of Gastroenterology and Hepatology
- Published
- 2024-11-06
- DOI
- https://doi.org/10.1111/jgh.16799
- Primary Topic
- Colorectal Cancer Screening and Detection
- Type
- article
- Field-Weighted Citation Impact
- 0.00